培菲康与思密达联合治疗小儿腹泻的临床疗效和安全性分析
【摘 要】目的:探讨培菲康联合思密达对小儿腹泻的临床治疗效果。方法:选取我院2018年1月-2019年1月收治的80例小儿腹泻患者,随机分成对照组和实验组,各40例,比较两组患儿的用药效果。结果:实验治疗总有效率为95%显著高于对照组治疗总有效率62.5%,差异有统计学意义(P<0.05)。结论:通过培菲康联合思密达治疗小儿腹泻具有良好的治疗效果和安全性,可以在临床治疗中进行推广应用。【关键词】培菲康;思密达;联合;小儿腹泻;疗效
Clinical efficacy and safety analysis of combination of bificon and Smecta in the treatment of infantile diarrhea
Abstract:Objective To investigate the clinical effect of Beifeikang combined with Smecta on infantile diarrhea.Methods 80 cases of children with diarrhea admitted to our hospital from January 2018 to January 2019 were randomly divided into control group and experimental group ......
您现在查看是摘要页,全文长 3949 字符。